U.S. stocks traded mostly higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Thursday.
The Dow traded down 0.03% to 33,942.78 while the NASDAQ rose 0.75% to 13,603.24. The S&P 500, also rose, gaining, 0.27% to 4,377.39.
Gainers
Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private investment positions.
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 70 points on Thursday.
The Dow traded down 0.11% to 33,912.98 while the NASDAQ rose 0.54% to 13,574.90. The S&P 500, also rose, gaining, 0.10% to 4,369.87.
Aeglea BioTherapeutics Inc (NASDAQ: AGLE) has acquired Spyre Therapeutics, a privately-held biotechnology company focused on developing antibody therapeutics